04/11/2025 4:29 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) SPRINGER TIMOTHY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2025 6:04 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/20/2025 6:50 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) SPRINGER TIMOTHY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2025 6:04 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2025 6:06 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/03/2025 5:59 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2025 8:28 AM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
01/27/2025 6:04 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/15/2025 3:25 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) SPRINGER TIMOTHY A (Filed by)
| Form SCHEDULE 13D/A | |
01/15/2025 3:08 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) SPRINGER TIMOTHY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2025 11:15 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form EFFECT | |
Get the Latest News and Ratings for RNAC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cartesian Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
01/13/2025 11:15 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form EFFECT | |
01/13/2025 3:09 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Jewell Christopher M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2025 6:04 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/09/2025 11:15 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form EFFECT | |
01/09/2025 11:15 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form EFFECT | |
01/09/2025 11:15 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form EFFECT | |
01/10/2025 5:00 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form POS AM | |
01/10/2025 5:01 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form POS AM | |
01/08/2025 3:33 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 424B7 | |
01/08/2025 3:38 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 424B7 | |
01/08/2025 3:30 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 424B3 | |
01/07/2025 7:04 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Davis Blaine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/07/2025 7:04 PM | Brunn Carsten (Reporting) Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/07/2025 7:05 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) English Emily (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/07/2025 7:05 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Jewell Christopher M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/07/2025 7:05 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Miljkovic Milos (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/07/2025 7:05 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Kurtoglu Metin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/06/2025 3:21 PM | Brunn Carsten (Reporting) Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/30/2024 3:14 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Singer Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/30/2024 3:11 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) English Emily (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/23/2024 7:22 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) SPRINGER TIMOTHY A (Filed by)
| Form SCHEDULE 13D/A | |
12/23/2024 4:20 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) SPRINGER TIMOTHY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2024 3:16 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
12/11/2024 3:28 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Kurtoglu Metin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2024 3:21 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) Kurtoglu Metin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/09/2024 3:36 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) Kurtoglu Metin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024 5:03 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/21/2024 5:50 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Jewell Christopher M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2024 5:51 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Singer Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2024 5:52 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Kurtoglu Metin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Crypto’s crashing…but we’re still profiting (Ad) Most traders are panicking right now.
Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess.
The news is screaming fear.
But while most traders watch their portfolios tank… my friend Joel and his team at The Crypto Code are doing the opposite. |
11/21/2024 3:45 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) Kurtoglu Metin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024 8:44 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) SPRINGER TIMOTHY A (Filed by)
| Form SC 13D/A | |
11/18/2024 6:28 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Miljkovic Milos (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/18/2024 6:32 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Kurtoglu Metin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/18/2024 6:35 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) SPRINGER TIMOTHY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/18/2024 6:23 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Jewell Christopher M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/18/2024 3:24 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) Kurtoglu Metin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2024 4:07 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) Kurtoglu Metin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024 6:31 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/07/2024 6:06 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2024 6:19 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/15/2024 3:53 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Kalayoglu Murat (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 3:30 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) Kalayoglu Murat (Filed by)
| Form SC 13D/A | |
10/15/2024 3:43 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Hoge Elizabeth (Reporting) Seven One Eight Three Four Irrevocable Trust (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2024 5:08 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) SPRINGER TIMOTHY A (Filed by)
| Form SC 13D/A | |
10/04/2024 4:58 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) SPRINGER TIMOTHY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/01/2024 11:15 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form EFFECT | |
10/01/2024 3:36 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 424B7 | |
09/27/2024 3:13 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) SPRINGER TIMOTHY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/27/2024 3:20 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) SPRINGER TIMOTHY A (Filed by)
| Form SC 13D/A | |
09/26/2024 6:02 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/23/2024 6:03 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/20/2024 3:17 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form S-1/A | |
08/16/2024 3:02 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form DEF 14A | |
08/14/2024 3:41 PM | BARABE TIMOTHY C (Reporting) Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 3:43 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) SPRINGER TIMOTHY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/12/2024 8:40 AM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) FMR LLC (Filed by)
| Form SC 13G | |
08/08/2024 6:04 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2024 6:07 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/02/2024 6:45 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form PRE 14A | |
08/02/2024 6:34 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
07/17/2024 10:45 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
07/12/2024 5:12 PM | Artal International S.C.A. (Filed by) Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject)
| Form SC 13G/A | |
07/05/2024 3:02 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) SPRINGER TIMOTHY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2024 3:15 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) SPRINGER TIMOTHY A (Filed by)
| Form SC 13D/A | |
07/02/2024 5:30 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/17/2024 6:54 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/22/2024 6:08 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/10/2024 9:03 AM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
05/08/2024 6:03 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 6:06 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024 8:09 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024 6:57 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form DEFA14A | |
04/26/2024 6:57 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form DEFA14A | |
04/22/2024 5:25 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/19/2024 3:49 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) English Emily (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |